ANI PR Wire
17 Jan 2023, 15:15 GMT+10
New Delhi [India], January 17 (ANI/PNN): The South Korean Company Stand Up Therapeutics Co., Ltd. specializes in researching gene therapies for paralyzed spinal cord injury patients. With the introduction of their alliance, industry leaders in gene delivery technology Stand Up Therapeutics and VectorBuilder Inc. will build a GMP-grade gene delivery system.
VectorBuilder, headquartered in Chicago, Illinois, with other offices in North America, Europe, China, Japan, Korea, Australia, and Israel, is the world's largest provider of custom viral and non-viral gene delivery vectors. Over eighty thousand distinct vectors are developed annually for use by scientists around the world. VectorBuilder's Good Manufacturing Practice (GMP) facilities have attracted more than 50,000 clients, including the world's leading pharmaceutical corporations and institutions, who rely on its gene delivery systems. We provide delivery methods and gene therapy options.
Under the terms of the agreement between the two firms, VectorBuilder will in the future development and distribute gene therapy products designed by Stand Up Therapeutics. The objective is to achieve worldwide preeminence.
When VectorBuilder's Chief Scientist Bruce Lahn was asked about Stand Up Therapeutics' gene therapy for the universal treatment of paralysis, he responded, "VectorBuilder is quite interested in that." As the undisputed leader in the design and GMP fabrication of gene delivery vectors, I feel this is an excellent opportunity for VectorBuilder to sell this product to Stand Up for Patients worldwide.
"Stand Up Therapeutics is the only company in the world with the technology to cure paralyzed patients owing to spinal cord damage," said Dr Junsang Yoo, the company's chief executive officer (STUP-001). The team at Stand Up Therapeutics is dedicated to developing a treatment for catastrophically injured paralyzed patients. Using the direct cross-differentiation PIPELINE technology, Stand Up Therapeutics plans to develop treatments for Parkinson's disease (STUP-002), stroke (STUP-003), spinal stenosis (STUP-004), and myocardial infarction (STUP-005).
Four paraplegic patients are scheduled to commence a phase I/IIa clinical study of the gene therapy treatment STUP-001 for SCI in the first quarter of 2023.
As an example, think about Stand Up Therapeutics Co., Ltd.
The primary emphasis of Stand Up Therapeutics Co., Ltd. is regenerative neurology, namely fibroblast-to-motor-neuron in vivo gene therapy. These remedies have been developed using contemporary medical science and methodologies. The direct lineage reprogramming strategy of Stand Up Therapeutics will benefit paralyzed patients of varying severity. Direct lineage reprogramming is anticipated to be used to treat individuals with spinal cord and brain damage. Approximately 1,9 per cent of the global population falls under this category. If Stand Up Therapeutics can improve the reliability and safety of direct reprogramming and gene therapy, it will be able to generate more drugs.
Visit http://stutps.com for additional details.
This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)
Get a daily dose of South East Asia Post news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to South East Asia Post.
More InformationHONG KONG: In a bid to tackle its declining birth rate, China will soon require all major hospitals to offer epidural anesthesia during...
WARSAW, Poland: Poland held a second round of voting in its presidential election on Sunday, but exit polls show the race is too close...
WEST JERUSALEM, Israel: Israeli forces stopped a boat heading to Gaza and detained Greta Thunberg and other activists on board early...
MELBOURNE, Australia: A second embryo mix-up in just two months has pushed one of Australia's largest IVF providers back into the spotlight,...
WASHINGTON, D.C. A public fight between U.S. President Donald Trump and billionaire Elon Musk has taken over social media, especially...
DERA BAJWA, Pakistan: Amir Ali, a 21-year-old man from Pakistan, dreamed of going to Europe for a better life. He was promised a visa...
BURBANK, California: Warner Bros Discovery is officially breaking itself in two. In a move that signals a major pivot for the media...
NEW YORK, New York - U.S. stocks closed modestly lower Wednesday despite a tentative trade agreement between the United States and...
Throughout human history, zoonotic diseases, illnesses that jump from animals to humans, have shaped civilizations, triggered pandemics,...
WASHINGTON, D.C.: A boom in U.S. solar energy installations may be running out of steam as shifting federal priorities, new tariffs,...
NEW YORK CITY, New York: Oil prices remained steady on June 9 as investors looked ahead to the outcome of the U.S.-China trade talks...
CHANDRAPUR/SOLAPUR (India): As India doubles down on coal to fuel its growing energy needs, an invisible crisis is surfacing: the country...